Stop Waiting for the FDA to Approve BPC-157. It Was Never About Safety.
The FDA’s 2026 ruling on BPC-157 isn’t about protecting public health; it’s about maintaining jurisdictional control over unregulated peptides. Despite massive user-reported therapeutic benefits, the agency is creating a legal minefield that criminalizes individual users just to protect its own gatekeeping power.